Top 10 Medical Device Angel Investors in France

Last updated: Apr 2024 A list of 10 angel investors that invest in Medical device startups based in France. We rank investors based on the number of investments they made in Medical device companies from France. We update this investor list every month.

Top 10 Medical Device Angel Investors in France

Investor	Medical Device France investments
Yann Fleureau	2
Guillaume Richard	2
Daniel Caille	2
Gerard Hascoet	1
Rajat Khare	1
Pierre Olivier Goineau	1
Christophe Ricard	1
Richard Leparmentier	1
Sacha Loiseau	1
Siddarth Satish	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Yann sets the vision and strategic direction for Cardiologs and is the guardian of company culture. He is a frequent speaker at industry conferences and is recognized as a thought leader in the application of AI in healthcare. Yann graduated with a degree in Computer Science and Biology from Ecole Polytechnique Paris (X) and the Silicon ValleyInnovation and Entrepreneurship program at UC Berkeley.He was recently named one of MIT Technology Review's Innovators Under 35 in Europe and BNP Paribas European Innovator of the Year. Yann is passionate about the intersection of new technology & clinical practice and is excited to be building a leading company that will help usher in a new era for healthcare worldwide.

Investment focus

Health Care, Medical Device
Series A, Series B
France

Portfolio highlights

Sonio — With Sonio, prenatal ultrasound professionals improve each step of their workflow. Democratizing high-quality care through medical-grade AI.
Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.

Guillaume Richard is the Founder, Chairman & CEO at Oui Care.He attended EDHEC Business School.

Investment focus

Medical, Software, Health Care
Pre-Seed, Series A
France

Portfolio highlights

HypnoVR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.

Daniel Caille

Investment focus

Elderly, Medical, Software
Series A, Pre-Seed, Funding Round
France

Portfolio highlights

HypnoVR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
Medylink —
CetteFamille — CetteFamille is an economical alternative to retirement homes in France. It is a French network of professional and accredited families to welcome the elderly.CetteFamille is a warm, economical and tailor-made alternative to the retirement home. CetteFamille is a site of connection and a company of services to the person allowing seniors to finda trained and selected family close to home. CetteFamille offers seniors and their families an offer of contact and a follow-up service to carry out all the administrative procedures.On www.cettefamille.com, caregivers of seniors can register to meet a family available nearby. The teams at CetteFamille are responsible for contacting them to study the request and ensure a meeting with the family most appropriate to meet his needs.

Mr. Hascoet is an Executive Chairman at MD Start and was a Founder and CEO at Technomed.

Investment focus

Health Care, Medical Device, Medical
Seed, Series A, Series B
France

Portfolio highlights

Corwave — The CorWave LVAD utilizes an undulating disc wave pumping mechanism, replacing the high speed, high shear impeller of current continuous flow rotary pumps. The result is much less trauma to the blood, reducing clotting and bleeding complications. The high frequency actuation of the Corwave pump provides for pulsatile flow that mimics the action ofthe native heart. Current LVADs provide only continuous flow with no significant pulsation, due to the high inertia of their rotors. Its low power consumption and small size will facilitate totally implantablity with the incorporation of a wireless energy transfer system.
HEPTA Medical — HEPTA Medical develops a sensor, embedded into a bronchoscopic or percutaneous ablation catheter, which provides temperature-based feedback. This enables real-time dosing to precisely target and ablates pulmonary nodules, the precursor of lung cancer, without the need for surgery or radiation.

An Internet-age investor and a serial entrepreneur, Rajat Khare is the founder of the European (luxembourg based) investment firm -Boundary Holding. A prominent investment fund with presence in France and Luxembourg, Boundary Holding invests globally in spaces related to Artificial Intelligence (AI) and allied fields such as Data Analytics andMining, Machine learning and Predictive Analytics.Each field contributes significantly to the development of various industries. Data Analytics optimizes business decisions, enhances healthcare, and fortifies cybersecurity. Machine Learning propels autonomy, refines user experiences, and advances predictive maintenance. Predictive Analytics revolutionizes finance, streamlines supply chains, improves healthcare, and tailors customer relations.Boundary Holding primarily acts as a Bridge fund for startups and organizations, facilitating funds across Safe cities, Internet of Things, Algorithmic trading, AI and Analytics. The company has a network of startup programs around the world.Rajat khare holds a Computer Science degree from IIT-Delhi, and has interned at RUCA, University of Antwerp in the Department of Mathematics. He has been a keynote speaker in over 20 major conferences and events across the globe. His work as an investor has also been cited as a case study in the course of Entrepreneurship run by Professor Patrick Turner in INSEAD Business School. He has authored various research papers published in international conferences and books, such as Data Mining V by WIT press. Rajat has co-authored Make the Move on entrepreneurship and Science of Achievement on education. Both the books reflect Rajat’s inclination towards promoting entrepreneurship and a holistic incubation of innovative solutions around the world.An active member of The Indus Entrepreneurs (TIE), the IIT Delhi alumni association and the Indian angel network, Rajat proactively supports and encourages entrepreneurs and entrepreneurial ventures around the world. For his efforts to promote entrepreneurship, he was appreciated by Dr APJ Abdul Kalam at the President’s house in 2006, spotlighting his significant role in promoting entrepreneurship on a global scale.

Investment focus

Drones, Robotics, Security
Series A, Series B, Funding Round
France, Switzerland, Germany

Portfolio highlights

CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
Scewo — Scewo is a medical technology platform that develops stair-climbing wheelchair. Founded in 2017, the company is headquartered in Winterthur, Zurich, Switzerland.
EdallSystems — EdallSystems provide Educational Service (Aerospace Engineering Training), UAV development, Engineering Service(Lab Development) and consulting in INDIA. Their moto is to become a major Product Development company in the filed of Aerospace In India and to support and Develope Aerospace products in India.

Pierre Olivier Goineau - President @ Neuronax

Investment focus

Medical, Biopharma, Health Care
Funding Round
France

Portfolio highlights

Ixaltis — Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.The company was born out of the combined expertise of scientists specialized in urology, pharmaceutical experts and experienced managers: Dr. Philippe Lluel, Christian Chavy, Stefano Palea, Dr. Roberto Gradnik andProfessors Pascal Rischmann and Xavier Gamé. The vision of IXALTIS is to develop treatments for genito-urinary tract diseases with still a high unmet medical need, by identifying drugs which had already reached clinical stage and reexplore these for use in genitourinary tract disorders.IXALTIS has established a proprietary position covering Litoxetine for use in urogenital and other disorders based on its specific mechanism of action.

Christophe Ricard CEO of OM Pharma

Investment focus

Life Science, Biotechnology, Medical Device
Seed, Series B
France

Portfolio highlights

Antabio — Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.

Richard Leparmentier

Investment focus

Health Care, Medical Device
Series A, Series B
France

Portfolio highlights

Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.

Sacha Loiseau is the Chairman, CEO and Founder at Mauna Kea Technologies. He attended Polytechnic university.

Investment focus

Health Care, Medical Device, Gaming
Series A, Pre-Seed, Series B
France

Portfolio highlights

AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.

Siddarth Satish is the Chief Executive Officer of Gauss Surgical. He founded the company in 2011 and served as CTO and Chairman of the Board until 2015. In his operating roles, he has led the company from invention through six US/EU regulatory approvals (including FDA De Novo), and into its commercial phase of growth. Siddarth previouslyserved as an EIR at StartX, Stanford’s Startup Accelerator, and as a SIMdesign Fellow at the Stanford University School of Medicine. He holds a B.S. in Chemical Engineering from the University of California, Berkeley, and an M.S. in Bioengineering from the UC Berkeley/UCSF Joint Graduate Group in Bioengineering, and he is a named inventor on over 25 issued or pending patents.